Nash Christine A 4
4 · Rallybio Corp · Filed Apr 6, 2022
Insider Transaction Report
Form 4
Rallybio CorpRLYB
Nash Christine A
Director
Transactions
- Award
Option (Right to Buy)
2022-04-04+26,880→ 26,880 totalExercise: $8.22Exp: 2032-04-04→ Common Stock (26,880 underlying)
Footnotes (1)
- [F1]The option is granted under the Company's 2021 Equity Incentive Plan. The option vests in three equal annual installments beginning on April 4, 2023.